Valbiotis SAS Asset Resilience Ratio
Valbiotis SAS asset resilience ratio. Valbiotis SAS (ALVAL) has an Asset Resilience Ratio of 45.67% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Valbiotis SAS to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Valbiotis SAS (2015–2025)
Asset resilience ratio of Valbiotis SAS from 2015 to 2025. This chart shows how Valbiotis SAS's Asset Resilience Ratio has changed over time. Read Valbiotis SAS (ALVAL) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Valbiotis SAS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Valbiotis SAS.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €6.57 Million | 45.67% |
| Short-term Investments | €0.00 | 0% |
| Total Liquid Assets | €6.57 Million | 45.67% |
Asset Resilience Insights
- Very High Liquidity: Valbiotis SAS maintains exceptional liquid asset reserves at 45.67% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Valbiotis SAS Industry Peers by Asset Resilience Ratio
Compare Valbiotis SAS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Saputo Inc
TO:SAP |
Packaged Foods | 3.36% |
|
Guangdong Haid Group Co Ltd
SHE:002311 |
Packaged Foods | 5.88% |
|
The a2 Milk Company Ltd
AU:A2M |
Packaged Foods | 5.10% |
|
Unibel S.A
PA:UNBL |
Packaged Foods | 0.24% |
|
Bega Cheese Ltd
AU:BGA |
Packaged Foods | 3.44% |
|
DXN HOLDINGS BHD.
KLSE:5318 |
Packaged Foods | 0.57% |
|
Seoul Food
KO:004410 |
Packaged Foods | 0.00% |
|
Diamond Food Indonesia PT
JK:DMND |
Packaged Foods | 4.99% |
Valbiotis SAS Asset Resilience Ratio by Year (2015–2025)
Valbiotis SAS asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Valbiotis SAS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 45.67% | €6.57 Million ≈ $7.68 Million |
€14.39 Million ≈ $16.82 Million |
+5.34pp |
| 2024-12-31 | 40.33% | €7.91 Million ≈ $9.24 Million |
€19.61 Million ≈ $22.92 Million |
+32.62pp |
| 2023-12-31 | 7.70% | €2.57 Million ≈ $3.00 Million |
€33.31 Million ≈ $38.94 Million |
+5.71pp |
| 2022-12-31 | 1.99% | €541.00K ≈ $632.49K |
€27.17 Million ≈ $31.77 Million |
+0.09pp |
| 2021-12-31 | 1.90% | €541.00K ≈ $632.49K |
€28.48 Million ≈ $33.29 Million |
-1.24pp |
| 2020-12-31 | 3.14% | €660.00K ≈ $771.61K |
€21.00 Million ≈ $24.55 Million |
-8.98pp |
| 2019-12-31 | 12.12% | €1.82 Million ≈ $2.13 Million |
€15.02 Million ≈ $17.55 Million |
-73.47pp |
| 2018-12-31 | 85.59% | €10.19 Million ≈ $11.91 Million |
€11.91 Million ≈ $13.92 Million |
+2.21pp |
| 2017-12-31 | 83.38% | €10.60 Million ≈ $12.39 Million |
€12.71 Million ≈ $14.86 Million |
+50.80pp |
| 2016-12-31 | 32.57% | €529.00K ≈ $618.46K |
€1.62 Million ≈ $1.90 Million |
+1.94pp |
| 2015-12-31 | 30.63% | €355.01K ≈ $415.05K |
€1.16 Million ≈ $1.35 Million |
-- |
About Valbiotis SAS
Valbiotis SA engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France and Asia. The company offers supplements for immunity and vitality, health and wellbeing, metabolic and cardiovascular health, and beauty and physical comfort. It also develops TOTUM-63 for the reduction of fasting blood glucose and treatment of type 2 diabetes; T… Read more